The world's first international clinical guidelines to help prevent and treat heart complications in children undergoing cancer treatment have been created. The guidelines, published in JACC:Advances, cover cardiovascular disease assessment, screening and follow-up, for pediatric patients receiving cancer treatment with new molecular therapies, immunotherapy, chemotherapy and radiotherapy. The expert consensus, led by researchers from the